French Gauge) and of solid construction so that they cannot be introduced percutaneously over a wire (Seldinger, I953) . The stiffer construction of these instruments compared with conventional catheters makes their intravascular manipulation more difficult, and there is, therefore, a greater risk of intimal damage and of arrhythmias. Extensive manipulation may also contribute to the early failure of these expensive instruments.
The use of a short sheath (Desilets and Hoffman, I965) allows percutaneous introduction of solid ended catheters but the problem of manipulation remains. In order to solve both the problem of percutaneous introduction and of accurate placement in the circulation with the minimum of manipulation the St. Thomas' long sheath technique was developed.
Method Ultra-thin wall non radio-opaque 'teflon' medical grade tubing (Becton, Dickinson U.K. Ltd.) is used to manufacture the disposable long sheaths. The tubing size appropriate for the various probe sizes is given in This tubing is not made to exact internal diameter specifications and as a result there is some variation in preciseness of fit between different batches of tubing and the same size catheter probe. For the best results the size of tubing should be selected which closely fits the catheter but which is not so tight that it prevents easy insertion of the catheter into the sheath.
These long sheaths have been used in three different ways: I) Venous transseptal route. The sheath is passed over a transseptal catheter across the interatrial septum and down through the mitral valve to the left ventricle. This route is used in patients with aortic valve disease or aortic valve replacements. Exceptions are those with a (Brockenbrough and Braunwald, I96o) . The long sheath is fitted over the 'teflon' catheter and cut to such a length that with the catheter fully advanced the distal end of the sheath lies just proximal to the side holes of the catheter (Fig. i) . A sterile 'band-aid' (Johnson and Johnson) is stuck securely round the proximal end of the sheath to form a flange (Fig. 2) to prevent any possibility of the whole sheath advancing into the patient.
The transseptal catheter and long sheath are introduced via a right long saphenous vein cut-down or by percutaneous puncture of the right femoral vein (Seldinger technique) and advanced to the superior vena cava. A Brockenbrough needle is inserted and the atrial septum is punctured immediately below the limbic ledge in the floor of the fossa ovalis (Bloomfield and SinclairSmith, I965) . When needle puncture has been achieved, the catheter and needle are advanced to the left atrium. The passage of the catheter across the septum is usually appreciated by the operator. The needle is then withdrawn until the tip lies just within the 'teflon' catheter. The catheter and sheath are then advanced over the needle and the passage of the sheath across the septum can also be felt by the operator. With the needle removed the catheter and sheath may be passed through the mitral valve to the left ventricle. This manoeuvre is best achieved by the insertion of a 'teflon' coated guide wire which is passed through the mitral valve. Then the catheter and sheath are advanced to the left ventricle over the wire. By using a soft ended guide wire there is less risk of perforating the atrial wall than when manipulating the rigid 'teflon' transseptal catheter.
Once the catheter and sheath are in the left ventricle, the sheath is advanced slightly over the catheter which is then withdrawn holding the sheath firmly. With the sheath in place a catheter tip micromanometer, endomyocardial bioptome, or a twin lumen catheter can be route was also used, and in IO the sheath was advanced to the right ventricle after it had been withdrawn across the atrial septum. In one patient, the venous transseptal, arterial left ventricular, and venous right ventricular routes were all used. The long sheath was passed by the arterial route alone in 2I patients (age range I7 to 66), by the venous right ventricular route alone in 3 patients (age range 9 to 68), and by both routes in 5 patients. The majority of the patients in the series suffered from valvular heart disease, but patients with primary myocardial disease, congenital heart disease, and ischaemic heart disease were also studied (Table   3 ). i) Venous transseptal route Of the I58 transseptal catheterizations attempted, it was not possible to introduce the sheath to the left (Mendel, I968) In the present series, a standard Brockenbrough transseptal needle and catheter was used. If the interatrial septum is punctured in the floor of the fossa ovalis, the catheter and sheath pass easily to the left atrium, and in only 5 (3.2%) was it not possible to place the sheath in the left atrium. In I24 out of I32 patients, the left ventricle was entered by this route and in only 8 was it impossible (6%). The passage of the catheter and sheath through the mitral valve is very much easier and safer if a 'teflon' coated guide wire is passed to the left ventricle across the mitral valve and the catheter and sheath advanced over the wire. The stiff 'teflon' transseptal catheter is replaced by a blunt ended catheter to avoid perforation of the left atrial or ventricular wall. Free back flow of blood must be allowed to occur down the sheath to remove all blood clot and air when exchanging catheters. Failure to do this probably caused air embolism in one patient.
A further use of this ultra-thin wall 'teflon' tubing, not previously described, is for introducing the micromanometer or endomyocardial bioptome into the left ventricle by the arterial route or into the right ventricle by the venous route. The arterial route is used when the transseptal route is contraindicated or where it has not been possible to cross the mitral valve. In all cases in this series it was possible to pass the sheath to the left ventricle but in one case the Telco micromanometer would not pass up the sheath beyond a tortuous iliac artery. In 2 cases a mild hemiplegia occurred, possibly unrelated to the use of the sheath, and there was one case of femoral artery occlusion. If possible the use of the arterial sheath is avoided in patients with a very low cardiac output or small arteries. The catheter tip micromanometer passes easily to the left ventricle down the sheath without risk of damaging the intima or catheter tip and can then be replaced by a catheter suitable for angiography.
The incidence of complications is similar to the American Heart Association's co-operative study on cardiac catheterization (Braunwald and Swan, I968 
